A pilot study evaluating the clinical and immunomodulatory effects of an orally administered extract of Dendrobium huoshanense in children with moderate to severe recalcitrant atopic dermatitis

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 2, 2011, Pages 367-375

  Wu, Keh Gong ^a   Li, T H ^a,b   Chen, C J ^a,b   Cheng, H I ^a,b   Wang, T Y ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

Atopic dermatitis; Children; Dendrobium huoshanense; Polysaccharide

Indexed keywords

DENDROBIUM HOUSHANENSE EXTRACT; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; PLANT EXTRACT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; DENDROBIUM HUOSHANENSE EXTRACT; IMMUNOGLOBULIN E; CYTOKINE; IMMUNOLOGIC FACTOR; POLYSACCHARIDE;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CASE STUDY; CHILD; CLINICAL ARTICLE; DENDROBIUM; DENDROBIUM HOUSHANENSE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG ISOLATION; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; INSOMNIA; MALE; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RATING SCALE; SCHOOL CHILD; ABSENCE OF SIDE EFFECTS; ALLERGIC RHINITIS; ASTHMA; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG ACTIVITY; DRUG SCREENING; DRUG TREATMENT FAILURE; EOSINOPHIL COUNT; EVENING DOSAGE; FAMILY HISTORY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATING ACTIVITY; INVESTIGATOR GLOBAL ATOPIC DERMATITIS ASSESSMENT; MEDICAL HISTORY; MORNING DOSAGE; ONSET AGE; PREVALENCE; RECALCITRANT ATOPIC DERMATITIS; SCORING ATOPIC DERMATITIS; SCORING SYSTEM; SKIN ALLERGY; SKIN DISEASE ASSESSMENT; SLEEP DISORDER ASSESSMENT; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD; CHEMISTRY; HOSPITALIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; ORAL DRUG ADMINISTRATION; PATHOLOGY; TAIWAN; TIME;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; DENDROBIUM; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; PILOT PROJECTS; PLANT EXTRACTS; POLYSACCHARIDES; PRURITUS; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051764498     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400210     Document Type: Article

References (21)

1. Akdis CA, Akdis M, Bieber, T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118:152-69. (Pubitemid 43946480)
2. Krakowski AC, Eichenfield, LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics 2008; 122:812-24.
3. Leung DYM, Soter NA. Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Deratol 2001; 44:S1-S12. (Pubitemid 32047908)
4. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004; 113:651-7. (Pubitemid 38544154)
5. Paller AS, Lebwohl M, Fleischer AB, et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies. J Am Acad Dermatol 2005; 52:810-22. (Pubitemid 40614645)
6. Uehara M, Sugiura H, Sakurai K. A trial of oolong tea in the management of recalcitrant atopic dermatitis. Arch Dermatol 2001; 137:42-3. (Pubitemid 32096356)
7. Fung AY, Look PC, Chong LY, But PP, Wong E. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999; 38:387-92. (Pubitemid 29258126)
8. Ricci G, Dondi A, Patrizi A, Masi M. Systemic therapy of atopic dermatitis in children. Drugs 2009; 69:297-306.
9. Chen XM, Guo SX. Advance in the research of constituents and pharmacology of Dendrobium. Chinese Nat Prod Res Dev 2000; 13:70-75.
10. Hseih YS, Chien C, Liao SK, et al. Structure and bioactivity of the polysaccharides in medicinal plant Dendrobium huoshanense. Bioorg Med Chem 2008; 16:6054-68. (Pubitemid 351758834)
11. Ye Q, Qin G, Zhao W. Immunomodulatory sesquiterpene glycosides from Dendrobium nobile. Phytochemistry 2002; 61:885-890. (Pubitemid 35447159)
12. Zhao W, Ye Q, Tan X, Jiang H, Li X, Chen K, Kinghorn AD. Three new sesquiterpene glycosides from Dendrobium nobile with immunomodulatory activity. J Nat Prod 2001; 64:1196-200. (Pubitemid 32937891)
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol 1980; 92(S):44-47.
14. Wang L-H. Dendrobium plant YFY-HS1, U.S. PP16,746 P3, 2006.
15. Novak N. New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy 2009; 64:265-75.
16. Schmitt J, Schakel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: a systematic review. Acta Dermatol Venereol 2007; 87:100-11. (Pubitemid 46521989)
17. Gong YQ, Fan Y, Wu DZ, Yang H, Hu ZB, Wang ZT. In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent. Eur J Cancer 2004; 40:1554-65. (Pubitemid 38757744)
18. Overall CM, Wrana JL, Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 1991; 266:14064-71. (Pubitemid 21907461)
19. Toda M, Leung DY, Molet S, et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003; 111:875-81. (Pubitemid 36470263)
20. Zheng X, Nakamura K, Tojo M, et al. TGF-β1-mediated regulation of thymus and activation-regulated chemokine (TARC/CCL17) synthesis and secretion by HaCaT cells co-stimulated with TNF-α and IFN-γ. J Dermatol Sci 2002; 30:154-60. (Pubitemid 36159026)
21. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004; 113:334-40. (Pubitemid 38210559)